Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furniture Plc Regulatory News (DFS)

Share Price Information for Dfs Furniture Plc (DFS)

Share Price is delayed by 15 minutes
Get Live Data
121.00    0.00 (0.00%)
Bid:
119.00
Ask:
121.00
Spread: 2.00 (1.681%)
Market Cap: £280.13m
DFS Live PriceLast checked at - London Stock Exchange

Intraday Dfs Furniture Plc Share Chart

COVID-19 Update

5 Nov 2020 07:00

RNS Number : 3083E
DFS Furniture PLC
05 November 2020
 

5 November 2020

 

DFS Furniture plc

 

COVID-19 Update

 

 

Manufacturing and deliveries continuing through current national lockdowns

Robust balance sheet; net cash position with access to over £300m of funds

Current lockdown measures not expected to materially impact profitability for the first half

 

DFS Furniture plc today issues an update in the light of increasing restrictions on the movement of people and trading activity being put in place by Governments to restrict the spread of COVID‐19 in many of the markets where the Group's brands trade.

 

Update on showrooms, manufacturing and delivery

As of today, the 5th November, following Government legislation all physical showrooms in England, the Republic of Ireland and Wales, are temporarily closed, which together represent 181 of our 208 showrooms across the estate. All showrooms in all other territories are open and trading.

 

Under current legislation, in England our showrooms (169) are closed for four weeks from 5 November to 2 December. Our Welsh showrooms (7) are due to re-open on Monday 9 November, following 16 days of closure. Our Irish showrooms (5) are due to reopen on 1 December, following six weeks of closure. 

 

Our websites across all brands and territories remain open for business and are performing well. Based on our previous experience of lockdown we expect our online business to improve further. This will be supported by the temporary transfer of showroom colleagues to other areas of the business, including remotely assisting customers with web purchases.

 

Notwithstanding the showroom restrictions, we continue to manufacture, deliver and install orders safely into customer homes in all territories. Given the current very strong order bank levels, and the delivery lead times we are therefore operating at, we do not expect that this period of showroom closure will materially impact revenues and profitability for the first 26 weeks to 27 December 2020.

 

Furthermore, our experience of the prior lockdown periods was that substantially all order intake disrupted during the lockdown period was either deferred until showrooms reopened or was captured online. 

 

Strong Financial Position

Our balance sheet position remains robust. With the strength of recent trading, helped by associated working capital inflows, we currently hold a net cash position, with access to over £300m of available cash and undrawn bank facilities.

 

Our next scheduled trading update is the 12 January 2021, covering trading performance over the 26 weeks to 27 December 2020.

 

 

Enquiries:

DFS (enquiries via Tulchan)

Tim Stacey (Group CEO)

Mike Schmidt (Group CFO)

Phil Hutchinson (Investor Relations)

investor.relations@dfs.co.uk

 

Tulchan

James Macey-White

Jessica Reid

Amber Ahluwalia

+44 (0)20 7353 4200

dfs@tulchangroup.com

 

About DFS Furniture plc

DFS is the clear market leading retailer of living room furniture in the United Kingdom. We design, manufacture, sell and deliver to our customers an extensive range of furniture products. The business operates a retail network of living room furniture stores in the United Kingdom and Europe, together with an online channel. These have been established and developed gradually over 50 years of operating history. We attract customers to our stores and websites through our substantial and continued investment in nationwide marketing activities and our reputation for high quality products and service, breadth of product ranges and price points and favourable consumer financing options.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKQBKCBDDODK
Date   Source Headline
15th Nov 20247:00 amRNSHolding(s) in Company
31st Oct 20244:35 pmRNSHolding(s) in Company
31st Oct 202412:55 pmRNSHolding(s) in Company
28th Oct 202410:09 amRNSHolding(s) in Company
22nd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSAnnual Financial Report 2024 and Notice of AGM
17th Oct 20247:00 amRNSDirectorate Change
10th Oct 20242:34 pmRNSHolding(s) in Company
9th Oct 20243:16 pmRNSHolding(s) in Company
26th Sep 20241:48 pmRNSDirector/PDMR Shareholding
25th Sep 20247:00 amRNSFY24 Preliminary Results
6th Aug 20243:54 pmRNSHolding(s) in Company
12th Jul 20247:00 amRNSDirectorate Change
24th Jun 202411:45 amRNSHolding(s) in Company
12th Jun 20247:00 amRNSPre Close Trading Statement
3rd Jun 20247:00 amRNSTotal Voting Rights
3rd May 20247:00 amRNSTotal Voting Rights
9th Apr 20247:00 amRNSPost 2023 AGM Shareholder Engagement - Update
8th Apr 20247:00 amRNSHolding(s) in Company
19th Mar 20247:00 amRNSInterim Results
19th Jan 20247:00 amRNSTrading Statement
21st Dec 20233:40 pmRNSHolding(s) in Company
1st Dec 20233:36 pmRNSHolding(s) in Company
15th Nov 202312:36 pmRNSHolding(s) in Company
14th Nov 202312:12 pmRNSHolding(s) in Company
10th Nov 20233:26 pmRNSRESULTS OF AGM
7th Nov 20237:00 amRNSHolding(s) in Company
6th Nov 20237:00 amRNSHolding(s) in Company
20th Oct 202312:14 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSAnnual Financial Report
22nd Sep 202310:13 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSHolding(s) in Company
21st Sep 20237:00 amRNSFY23 Preliminary Results
7th Sep 20237:00 amRNS£250M NEW CREDIT FACILITIES SIGNED
17th Jul 20237:00 amRNSTrading Statement
12th Jul 20237:00 amRNSDirector Declaration
9th Jun 20237:00 amRNSDirectorate Change
8th Jun 202310:25 amRNSHolding(s) in Company
3rd May 20239:51 amRNSHolding(s) in Company
21st Apr 20231:54 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim Results
9th Feb 20237:00 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSDirectorate Change
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.